Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone

Northwestern University39 enrolled

Overview

The purpose of the study is to investigate the effectiveness of three lifestyle treatment programs varying in level of intensiveness on prevention of pioglitazone-induced weight gain and to measure the composition of the change in body weight.

The three lifestyle interventions were usual care (1 visit), standard care (4 total visits) and intensive care (10 total visits)

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Type 2 Diabetes Obesity

Interventions

Lifestyle modificationBEHAVIORAL

lifestyle intervention includes meal planning, food preparation, food label reading, dining out, and physical activity counseling

Eligibility

Sex: ALLMin age: 21 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * type 2 diabetes with BMI 27 or greater, glycated hemoglobin 7% or greater Exclusion Criteria: * insulin treated

Locations (1)

Northwestern Memorial Hospital Wellness Institute

Chicago, Illinois, United States

Outcomes

Primary Outcomes

change in body weight

Time frame: 24 weeks

Secondary Outcomes

change in body composition

Time frame: 24 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.